Non-Disclosure of Termination Event. In the event of a termination of this Agreement by Nuvios under Section 15.4, Nuvios will not disclose or cause to be disclosed to any third party the facts or circumstances regarding such termination, except for any such disclosure which is required by law (including if requested by any regulatory agency, taxing authority or commission of competent jurisdiction). As part of its obligation under this Section 13.3, except as is required by law (including if requested by any regulatory agency, taxing authority or commission of competent jurisdiction), Nuvios will not (i) issue any press release with respect to the facts or circumstances regarding termination of this Agreement under Section 15.4 or (ii) respond to press inquiries with respect to the facts or circumstances regarding such termination, other than responses which are materially consistent with public disclosure regarding the same by Ipsen. For purposes of clarity, nothing in this Section 13.3 shall prevent or restrict Nuvios from disclosing or causing to be disclosed publicly or to any third party the fact that Nuvios has terminated this Agreement for any reason or no reason if and when such termination has in fact occurred. In addition, notwithstanding anything express or implied in this Section 13.3 to the contrary, Nuvios shall be free to disclose the facts or circumstances regarding any termination of this Agreement by Nuvios under Section 15.4 to any third party to whom Nuvios is entitled to disclose Confidential Information of Ipsen pursuant to Section 12.3 (it being understood that, for purposes of this sentence and the provisions of Section 12.3, such facts and circumstances shall be treated as Confidential Information of Ipsen).
Appears in 6 contracts
Samples: License Agreement (Radius Health, Inc.), License Agreement (Radius Health, Inc.), License Agreement (Radius Health, Inc.)
Non-Disclosure of Termination Event. In the event of a termination of this Agreement by Nuvios Licensee under Section 15.414.3, Nuvios Licensee will not disclose or cause to be disclosed to any third party the facts or circumstances regarding such termination, except for any such disclosure which is required by law (including if requested by any regulatory agency, taxing authority or commission of competent jurisdiction). As part of its obligation under this Section 13.312.4, except as is required by law (including if requested by any regulatory agency, taxing authority or commission of competent jurisdiction), Nuvios Licensee will not (i) issue any press release with respect to the facts or circumstances * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. regarding termination of this Agreement under Section 15.4 14.3 or (ii) respond to press inquiries with respect to the facts or circumstances regarding such termination, other than responses which are materially consistent with public disclosure regarding the same by Ipsen. For purposes of clarity, nothing in this Section 13.3 12.4 shall prevent or restrict Nuvios Licensee from disclosing or causing to be disclosed publicly or to any third party the fact that Nuvios Licensee has terminated this Agreement for any reason or no reason if and when such termination has in fact occurred. In addition, notwithstanding anything express or implied in this Section 13.3 12.4 to the contrary, Nuvios Licensee shall be free to disclose the facts or circumstances regarding any termination of this Agreement by Nuvios Licensee under Section 15.4 14.3 to any third party to whom Nuvios Licensee is entitled to disclose Confidential Information of Ipsen pursuant to Section 12.3 11.3 (it being understood that, for purposes of this sentence and the provisions of Section 12.311.3, such facts and circumstances shall be treated as Confidential Information of Ipsen).
Appears in 5 contracts
Samples: License Agreement (Rhythm Pharmaceuticals, Inc.), License Agreement (Rhythm Pharmaceuticals, Inc.), License Agreement (Rhythm Pharmaceuticals, Inc.)
Non-Disclosure of Termination Event. In the event of a termination of this Agreement by Nuvios Licensee under Section 15.414.3, Nuvios Licensee will not disclose or cause to be disclosed to any third party the facts or circumstances regarding such termination, except for any such disclosure which is required by law (including if requested by any regulatory agency, taxing authority or commission of competent jurisdiction). As part of its obligation under this Section 13.312.4, except as is required by law (including if requested by any regulatory agency, taxing authority or commission of competent jurisdiction), Nuvios Licensee will not (i) issue any press release with respect to the facts or circumstances regarding termination of this Agreement under Section 15.4 14.3 or (ii) respond to press inquiries with respect to the facts or circumstances regarding such termination, other than responses which are materially consistent with public disclosure regarding the same by Ipsen. For purposes of clarity, nothing in this Section 13.3 12.4 shall prevent or restrict Nuvios Licensee from disclosing or causing to be disclosed publicly or to any third party the fact that Nuvios Licensee has terminated this Agreement for any reason or no reason if and when such termination has in fact occurred. In addition, notwithstanding anything express or implied in this Section 13.3 12.4 to the contrary, Nuvios Licensee shall be free to disclose the facts or circumstances regarding any termination of this Agreement by Nuvios Licensee under Section 15.4 14.3 to any third party to whom Nuvios Licensee is entitled to disclose Confidential Information of Ipsen pursuant to Section 12.3 11.3 (it being understood that, for purposes of this sentence and the provisions of Section 12.311.3, such facts and circumstances shall be treated as Confidential Information of Ipsen).
Appears in 2 contracts
Samples: License Agreement (Rhythm Holding Company, LLC), License Agreement (Rhythm Holding Company, LLC)